Genetic counselling legislation and practice in cancer in EU Member States
Language English Country England, Great Britain Media print
Document type Journal Article
Grant support
CAN.HEAL Consortium
101080009
European Union
P-MIP-22-187
Research Council of Lithuania Project
P-MIP-22-187
Research Council of Lithuania
AstraZeneca
PubMed
38905592
PubMed Central
PMC11293827
DOI
10.1093/eurpub/ckae093
PII: 7697112
Knihovny.cz E-resources
- MeSH
- European Union * MeSH
- Genetic Counseling * legislation & jurisprudence MeSH
- Genetic Testing legislation & jurisprudence MeSH
- Humans MeSH
- Neoplasms * genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Somatic and germline genetic alterations are significant drivers of cancer. Increasing integration of new technologies which profile these alterations requires timely, equitable and high-quality genetic counselling to facilitate accurate diagnoses and informed decision-making by patients and their families in preventive and clinical settings. This article aims to provide an overview of genetic counselling legislation and practice across European Union (EU) Member States to serve as a foundation for future European recommendations and action. METHODS: National legislative databases of all 27 Member States were searched using terms relevant to genetic counselling, translated as appropriate. Interviews with relevant experts from each Member State were conducted to validate legislative search results and provide detailed insights into genetic counselling practice in each country. RESULTS: Genetic counselling is included in national legislative documents of 22 of 27 Member States, with substantial variation in legal mechanisms and prescribed details (i.e. the 'who, what, when and where' of counselling). Practice is similarly varied. Workforce capacity (25 of 27 Member States) and genetic literacy (all Member States) were common reported barriers. Recognition and/or better integration of genetic counsellors and updated legislation and were most commonly noted as the 'most important change' which would improve practice. CONCLUSIONS: This review highlights substantial variability in genetic counselling across EU Member States, as well as common barriers notwithstanding this variation. Future recommendations and action should focus on addressing literacy and capacity challenges through legislative, regulatory and/or strategic approaches at EU, national, regional and/or local levels.
Cancer Centre Department of Epidemiology and Public Health Sciensano Brussels Belgium
Center for Medical Genetics Ghent University Hospital Ghent Belgium
Clinical Genetics Department The Cyprus Institute of Neurology and Genetics Nicosia Cyprus
Département de Génétique Institut Curie Paris France
Department of Clinical Genetics Erasmus Medical Center Rotterdam The Netherlands
Department of Clinical Genetics University Hospital of Copenhagen Rigshospitalet Copenhagen Denmark
Department of Human Genetics Hannover Medical School Hannover Germany
Department of Human Genetics Radboud University Medical Center Nijmegen The Netherlands
Department of Internal Medicine Erasmus Medical Center Rotterdam The Netherlands
Department of Medical Genetics Medical University of Sofia Sofia Bulgaria
Department of Medical Genetics Medical University of Warsaw Warsaw Poland
Department of Medical Genetics Unilabs Spišská Nová Ves Slovakia
Department of Tumor Biology and Genetics Medical University of Warsaw Warsaw Poland
Division of Clinical Genetics Department of Laboratory Medicine Lund University Lund Sweden
Eberly College of Science The Pennsylvania State University University Park PA USA
European Alliance for Personalised Medicine Brussels Belgium
Faculty of Dental Medicine and Health Josip Juraj Strossmayer University of Osijek Osijek Croatia
Faculty of Medicine Josip Juraj Strossmayer University of Osijek Osijek Croatia
Genetics and Personalized Medicine Clinic Tartu University Hospital Tartu Estonia
Hereditary Cancer Program Catalan Institute of Oncology IDIBGI Girona Spain
ICBAS School of Medicine and Biomedical Sciences University of Porto Porto Portugal
INSERM U830 Université Paris Cité Paris France
Institute of Applied Biosciences Centre for Research and Technology Hellas Thessaloniki Greece
Institute of Clinical and Preventive Medicine University of Latvia Riga Latvia
Institute of Genomics Faculty of Science and Technology University of Tartu Tartu Estonia
Institute of Hematology and Blood Transfusion Prague Czech Republic
Institute of Oncology Ljubljana Ljubljana Slovenia
Institute of Pediatrics Faculty of Medicine University of Debrecen Debrecen Hungary
Labdia Labordiagnostik Vienna Austria
Mater Dei Hospital Msida Malta
Medical School REGIOMED Coburg Germany
Medical School University of Rijeka Rijeka Croatia
Medical School University of Split Split Croatia
Ministry for Health Valleta Malta
National Center of Genetics Laboratoire National de Santé Dudelange Luxembourg
Riga East Clinical University Riga Latvia
St Anna Children's Cancer Research Institute Vienna Austria
St Catherine Specialty Hospital Zagreb Croatia
State Research Institute Center for Innovative Medicine Vilnius Lithuania
See more in PubMed
Ding L, Bailey MH, Porta-Pardo E, et al. Perspective on oncogenic processes at the end of the beginning of cancer genomics. Cell 2018;173:305–20.e10. PubMed PMC
Dyba T, Randi G, Bray F, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer 2021;157:308–47. PubMed PMC
Taber KAJ, Dickinson BD, Wilson M. The promise and challenges of next-generation genome sequencing for clinical care. JAMA Intern Med 2014;174:275–80. PubMed
Abacan M, Alsubaie L, Barlow-Stewart K, et al. The global state of the genetic counseling profession. Eur J Hum Genet 2019;27:183–97. PubMed PMC
Resta R, Biesecker BB, Bennett RL, et al. A new definition of genetic counseling: National Society of Genetic Counselors’ task force report. J Genet Couns 2006;15:77–83. PubMed
Bensend TA, Veach PM, Niendorf KB. What’s the harm? Genetic counselor perceptions of adverse effects of genetics service provision by non-genetics professionals. J Genet Couns 2014;23:48–63. PubMed
Borry P, Nys H, Goffin T, Dierickx K. Genetic Testing and Counselling: European Guidance. Report No.: 9033465795. Katholieke Universiteit, Centre for Biomedical Ethics and Law, 2007.
Rantanen E, Hietala M, Kristoffersson U, et al. Regulations and practices of genetic counselling in 38 European countries: the perspective of national representatives. Eur J Hum Genet 2008;16:1208–16. PubMed
Dragojlovic N, Borle K, Kopac N, et al. The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet Med 2020;22:1437–49. PubMed
Dragojlovic N, Kopac N, Borle K, et al. Utilization and uptake of clinical genetics services in high-income countries: a scoping review. Health Policy 2021;125:877–87. PubMed
Adeoye‐Olatunde OA, Olenik NL. Research and scholarly methods: semi‐structured interviews. J Am Coll Clin Pharm 2021;4:1358–67.
Angers A, Bohacova A, Kaye J, et al. Overview of EU national legislation on genomics. 2018. Available at: https://op.europa.eu/en/publication-detail/-/publication/503c92f7-ff55-11e8-a96d-01aa75ed71a1 (7 March 2023, date last accessed).
Council of Europe. Convention on Human Rights and Biomedicine. 1997. Available at: https://rm.coe.int/168007cf98 (3 March 2023, date last accessed).
Council of Europe. Additional Protocol to the Convention on Human Rights and Biomedicine Concerning Genetic Testing for Health Purposes. 2008. Available at: https://rm.coe.int/1680084824 (3 March 2023, date last accessed). PubMed
European Parliament. Regulation 2017/746 on In Vitro Diagnostic Medical Devices and Repealing Directive 98/79/EC and Commission Decision 2010/227/EU. 2017. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0746 (30 June 2023, date last accessed).
National Institute for Health and Disability Insurance (Belgium). Agreement Between the Medical Care Insurance Committee and the Centres for Human Heredity for Benefits in Kind Concerning Genetic Disorders: Genetic Counselling, DNA Tests Carried Out Abroad. 2011. Available at: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjjhb-ew4aAAxXUXaQEHecsCucQFnoECA0QAw&url=https%3A%2F%2Fwww.college-genetics.be%2Fpdf%2FConventieGeneticsCounsellor.pdf&usg=AOvVaw3m-ExyIxVRhAjES-UTaWLQ&opi=89978449 (7 July 2023, date last accessed).
Chamber of Deputies of Luxembourg. Hospital Law. 2018. Available at: https://www.legilux.public.lu/eli/etat/leg/loi/2018/03/08/a222/jo. (1 November 2023, date last accessed).
Secretary of State for Health Welfare and Sport (Netherlands). Planning Decision on Clinical Genetic Research and Genetic Counselling. 1998. Available at: https://wetten.overheid.nl/BWBR0014594/2018-08-01 (4 May 2023, date last accessed).
Ministry of Health (Bulgaria). Medical Standards for Medical Genetics. 2010. Available at: https://www.mh.government.bg/media/filer_public/2015/11/18/medicinska-genetika.pdf (23 June 2023, date last accessed).
Ministry of Health (Lithuania). Order of the Ministry of Health V-745 (2012). 2012. (10 March 2023, date last accessed).
Ministry of Health (Slovakia). The Concept of Healthcare in the Department of Medical Genetics. 2014. Available at: https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=web&cd=&ved=0CAIQw7AJahcKEwjo8_zo2Pf_AhUAAAAAHQAAAAAQAw&url=https%3A%2F%2Fwww.health.gov.sk%2FZdroje%3F%2FSources%2Fdokumenty%2Fvestniky_mz_sr%2F2014%2Fvestnik-21-22-2014.pdf&psig=AOvVaw3qpmyEymuaiTA8ZT3Bt5Sz&ust=1688650864404466&opi=89978449 (23 June 2023, date last accessed).
Ministry of Health (Italy). Guidelines for Medical Genetics. 2004. Available at: https://www.gazzettaufficiale.it/eli/id/2004/09/23/04A09280/sg (19 April 2023, date last accessed).
Ministry of Health (Romania). Establishment of the Medical Genetics Network. 2014. Available at: https://legislatie.just.ro/Public/DetaliiDocument/163135 (22 June 2023, date last accessed).
Barlow-Stewart K, Yeo SS, Meiser B, et al. Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genet Med 2006;8:24–32. PubMed
Allford A, Qureshi N, Barwell J, et al. What hinders minority ethnic access to cancer genetics services and what may help? Eur J Hum Genet 2014;22:866–74. PubMed PMC
Stenzinger A, Moltzen EK, Winkler E, et al. Implementation of precision medicine in healthcare – a European perspective. J Intern Med 2023;294:437–54. PubMed
Tecklenburg J, Vajen B, Morlot S, et al. OnkoRiskNET: a multicenter, interdisciplinary, telemedicine-based model to improve care for patients with a genetic tumor risk syndrome. BMC Health Serv Res 2022;22:1–8. PubMed PMC
World Health Organization. Global Strategy on Human Resources for Health: Workforce 2030. 2016.
European Union of Medical Specialists. European Training Requirements for the Specialty of Medical Genetics. 2023. Available at: https://www.uems.eu/__data/assets/pdf_file/0007/47518/ETR_Clinical-Genetics_approved.pdf (7 October 2023, date last accessed).
Otten E, Birnie E, Ranchor AV, van Langen IM. Telegenetics use in presymptomatic genetic counselling: patient evaluations on satisfaction and quality of care. Eur J Hum Genet 2016;24:513–20. PubMed PMC
Welch BM, Wiley K, Pflieger L, et al. Review and comparison of electronic patient-facing family health history tools. J Genet Couns 2018;27:381–91. PubMed PMC
Bucheit L, Johansen Taber K, Ready K. Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes. Hered Cancer Clin Pract 2019;17:2–10. PubMed PMC
van der Giessen J, Fransen MP, Spreeuwenberg P, et al. Communication about breast cancer genetic counseling with patients with limited health literacy or a migrant background: evaluation of a training program for healthcare professionals. J Commun Genet 2021;12:91–9. PubMed PMC
Little ID, Koehly LM, Gunter C. Understanding changes in genetic literacy over time and in genetic research participants. Am J Human Genet 2022;109:2141–51. PubMed PMC
European Partnership for Personalised Medicine. The Strategic Research & Innovation Agenda (SRIA) for Personalised Medicine (PM). 2023. Available at: https://www.icpermed.eu/media/content/EPPerMed-SRIA.pdf (1 November 2023, date last accessed).